Avibactam tomilopil (ARX-1796, AV-006) is an orally bioavailable prodrug of avibactam and functions as a β-lactamase inhibitor; it exhibits inhibitory activity against Class A and Class C β-lactamases, including extended-spectrum β-lactamases (ESBLs), AmpC enzymes, and Klebsiella pneumoniae carbapenemases (KPC).